249 related articles for article (PubMed ID: 9267855)
1. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
[TBL] [Abstract][Full Text] [Related]
2. Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes.
Krakowski M; Czobor P; Volavka J
Psychiatry Res; 1997 Jun; 71(1):19-26. PubMed ID: 9247978
[TBL] [Abstract][Full Text] [Related]
3. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of schizophrenic psychoses with haloperidol and valproate.
Dose M; Hellweg R; Yassouridis A; Theison M; Emrich HM
Pharmacopsychiatry; 1998 Jul; 31(4):122-5. PubMed ID: 9754845
[TBL] [Abstract][Full Text] [Related]
5. Effects of Shakuyaku-Kanzo-to on Extrapyramidal Symptoms During Antipsychotic Treatment: A Randomized, Open-Label Study.
Ota T; Miura I; Kanno-Nozaki K; Hoshino H; Horikoshi S; Fujimori H; Kanno T; Mashiko H; Yabe H
J Clin Psychopharmacol; 2015 Jun; 35(3):304-7. PubMed ID: 25839338
[TBL] [Abstract][Full Text] [Related]
6. [Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].
Chamorro García L
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(6):298-303. PubMed ID: 1687233
[TBL] [Abstract][Full Text] [Related]
7. Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol.
Inada T; Beasley CM; Tanaka Y; Walker DJ
Int Clin Psychopharmacol; 2003 Jan; 18(1):39-48. PubMed ID: 12490774
[TBL] [Abstract][Full Text] [Related]
8. Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?
Schoretsanitis G; Haen E; Hiemke C; Gründer G; Stegmann B; Schruers KR; Veselinovic T; Lammertz SE; Paulzen M
Int Clin Psychopharmacol; 2016 Sep; 31(5):259-64. PubMed ID: 27167902
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
10. [The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics].
Popov MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):28-33. PubMed ID: 18577931
[TBL] [Abstract][Full Text] [Related]
11. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
12. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
13. Intravenous biperiden in akathisia: an open pilot study.
Hirose S; Ashby CR
Int J Psychiatry Med; 2000; 30(2):185-94. PubMed ID: 11001281
[TBL] [Abstract][Full Text] [Related]
14. Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers.
Christoffersen CL; Meltzer LT
Neuropsychopharmacology; 1998 May; 18(5):399-402. PubMed ID: 9536454
[TBL] [Abstract][Full Text] [Related]
15. Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders.
König P; Chwatal K; Havelec L; Riedl F; Schubert H; Schultes H
Neuropsychobiology; 1996; 33(2):80-4. PubMed ID: 8927233
[TBL] [Abstract][Full Text] [Related]
16. No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients.
Silver H; Geraisy N
Biol Psychiatry; 1995 Sep; 38(6):413-5. PubMed ID: 8547463
[No Abstract] [Full Text] [Related]
17. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Eklund K; Forsman A
Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
[TBL] [Abstract][Full Text] [Related]
18. Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophrenia.
Ulrich S; Neuhof S; Braun V; Meyer FP
Int Clin Psychopharmacol; 1999 Jul; 14(4):219-28. PubMed ID: 10468314
[TBL] [Abstract][Full Text] [Related]
19. Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment.
Ulrich S; Neuhof S; Braun V; Danos P; Pester U; Hoy L
J Clin Psychopharmacol; 2000 Apr; 20(2):210-9. PubMed ID: 10770460
[TBL] [Abstract][Full Text] [Related]
20. Diurnal variations of extrapyramidal symptoms induced by haloperidol in schizophrenic subjects.
Torner C; Herrera-Estrella M; Gutiérrez JA; Aguilar-Roblero R
Int J Neuropsychopharmacol; 2003 Sep; 6(3):243-6. PubMed ID: 12974990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
